Senseonics SENS 深 滬
等待開盤 11-05 09:30:00 美东时间
9.115
+0.255
+2.88%
華盛通- 最 高9.48
- 今 開9.06
- 成交量 39.21万股
- 最 低 9.04
- 昨 收 8.86
- 總市值 4.82亿
- 52周最高 10.64
- 市盈率 靜 --
- 換手率 0.74%
- 52周最低 4.79
- 委 比 -33.33%
- 總股本 5287.41万
- 歷史最高 111.20
- 量 比 0.68
- 振 幅 4.97%
- 歷史最低 4.79
- 每 手 1
- 風險率 1.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅94.81%！富瑞上调ArriVent BioPharma(AVBP)目标价至30美元，维持"买入"评级
今日重点评级关注：富瑞：维持ArriVent BioPharma"买入"评级，目标价从18美元升至30美元；古根海姆：维持第一太阳能"买入"评级，目标价从282美元升至299美元
10-28 12:30
Beta Bionics Q3 Revenue Rises 30%, 2026 Outlook Narrows
Beta Bionics posted 30% Q3 2026 revenue growth to $35.5 million, narrowed full-year revenue guidance and detailed Mint-related revenue deferrals and product plans.
10-28 09:11
Beta Bionics (BBNX) 2026年第三季度业绩电话会：Mint发布与上调营收指引
Beta Bionics 2026年第三季度财报电话会：销售额增长30%至3550万美元，上调2026年业绩指引，Mint的推出计划仍定于2027年第一季度。
10-28 08:04
Senseonics Initiates First-In-Human Study Of Freedom
First clinical evaluation of investigational, transmitter-free one-year CGM marks an important milestone on Senseonics’ innovation roadmap, with potential launch in 2028 Built on the proven sensing technology behind Eversense 365 and supported by encouraging preclinical data to reduce development ri...
10-26 20:04
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
Senseonics Holdings, Inc. (NASDAQ: SENS) announced it will release its third quarter 2026 financial results after market close on November 9, 2026. Management will host a conference call at 4:30 p.m. ET on the same day, with a live webcast available on the company's website. Senseonics, a medical technology company, specializes in long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes, offering products like Ev...
10-21 12:00
Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript
Senseonics Holdings (AMEX:SENS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a con...
10-12 19:18
估值跌至十年低点！巴克莱首次覆盖26家美股医疗科技股，首选史赛克(SYK.US)等
巴克莱分析师Christopher Pasquale周二首次覆盖26家美股医疗科技公司，并将史赛克(SYK.US)和雅培(ABT.US)列入大盘医疗科技股推荐名...
10-08 13:58
美股大行评级 | 潜在涨幅175.74%！美光科技获DA Davidson上调目标价至3000美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持美光科技"买入"评级，目标价从2100美元升至3000美元；Leerink Partners：维持OmniAb"跑赢大市"评级，目标价从10美元升至12美元
10-08 12:30
Barclays Initiates Coverage On Senseonics Holdings with Equal-Weight Rating, Announces Price Target of $10
Barclays analyst Christopher Pasquale initiates coverage on Senseonics Holdings (NASDAQ:SENS) with a Equal-Weight rating and announces Price Target of $10.
10-07 21:11
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
Beta Bionics announced a partnership with Senseonics to integrate the iLet Bionic Pancreas and mint AID systems with Senseonics’ Eversense 365 CGM system. The integrated system is expected to launch in Q4 2026, offering users the most CGM manufacturer options for AID systems. The collaboration aims to expand reach and maximize choice for people with diabetes, combining advanced adaptive AID technology with long-term glucose sensing.
09-22 11:30
